Canada will not restrict AstraZeneca COVID-19 vaccine, says benefits outweigh risk
The Peninsula
OTTAWA: Canada's health ministry said on Wednesday it would not restrict use of AstraZeneca Plc's COVID-19 vaccine after a review showed the benefits outweighed the very rare risk of blood clots.
A separate advisory council had earlier recommended Canada stop offering the vaccine to people under 55. The panel is now reviewing that advice, the health ministry said in a statement. Denmark on Wednesday became the first country to stop using the vaccine altogether over a potential link to the rare blood clots. Other nations have imposed limits on its use.More Related News
Qatar sets benchmark in oncology education, hosting first-ever ESMO Advanced Course on Breast Cancer
Doha, Qatar: Hamad Medical Corporation (HMC) continues to play a vital role in enhancing healthcare in Qatar by hosting the ESMO Advanced Course on Br...
Qatar sets benchmark in oncology education, hosting first-ever ESMO Advanced Course on Breast Cancer
Doha, Qatar: Hamad Medical Corporation (HMC) continues to play a vital role in enhancing healthcare in Qatar by hosting the ESMO Advanced Course on Br...